News Daily News PCSK9 Inhibitor Alirocumab Receives Expanded Indication for CV Event Reduction Michael O'Riordan April 29, 2019
News Daily News Zero CAC Reliably Excludes CAD Among Stable, Symptomatic Patients, but Experts Debate Its Need Yael L. Maxwell April 18, 2019
News Daily News The Case for Collateralization: CABG’s Mechanism for Survival in Stable CAD Underappreciated by Patients L.A. McKeown February 26, 2019
News Daily News Age Shouldn’t Be a Barrier to Statin Therapy, Meta-analysis Suggests Michael O'Riordan February 08, 2019
News Daily News Bias Over Knowledge: Whether Patients Get Guideline-Recommended Statins Depends on Physician Beliefs Yael L. Maxwell January 10, 2019
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for November 2018 Shelley Wood November 30, 2018
News Daily News Certain Risk Factors Carry Higher MI Risk in Women Than in Men Shelley Wood November 23, 2018
News Conference News AHA 2018 EWTOPIA 75: Ezetimibe Bests Dietary Counseling Alone in Lowering Cardiovascular Risk for Elderly Japanese Patients Yael L. Maxwell November 16, 2018
News Conference News AHA 2018 Alirocumab Should Be Priced at $6,300 Annually: ODYSSEY Cost-Effectiveness Study Michael O'Riordan November 15, 2018
News Conference News VIVA 2018 Consulting the COMPASS for Rivaroxaban’s Role in Peripheral Vascular Disease L.A. McKeown November 15, 2018
News Conference News AHA 2018 Methotrexate, an Anti-inflammatory, Fails to Lower Risk of Cardiovascular Events: CIRT Michael O'Riordan November 10, 2018
News Conference News AHA 2018 REDUCE-IT: Prescription Fish Oil Prevents CV Events in Patients With High Triglycerides Todd Neale November 10, 2018
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for October 2018 Shelley Wood October 31, 2018
News Daily News Long-term Risk Factor Control Linked to Survival in COURAGE Substudy Yael L. Maxwell October 30, 2018
News Daily News Final Phase III Bempedoic Acid Trial Proves Positive for LDL-Lowering Shelley Wood October 29, 2018
News Daily News Coronary CTA for Suspected CAD Shows Advantages in Predicting Hard Outcomes Over 10 Years Yael L. Maxwell October 23, 2018
News Daily News Bariatric Surgery Reduces Hard CVD Events in Obese Patients With Type 2 Diabetes Michael O'Riordan October 18, 2018
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for September 2018 Shelley Wood October 02, 2018
News Conference News ESC 2018 ASCEND: Aspirin Doesn’t Look Good for Primary CV Prevention in Diabetic Patients Todd Neale August 26, 2018